The diagnostic contribution of magnetic resonance imaging in the detection of axillary metastasis after neoadjuvant chemotherapy.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 741, doi. 10.4149/neo_2022_220127N122
- By:
- Publication type:
- Article
Works matching IS 00282685 AND DT 2022 AND VI 69 AND IP 3
Results: 24
1
2
Epigenetic network of EZH2/SFRP1/Wnt in the epithelial-mesenchymal transition of laryngeal carcinoma cells.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 680, doi. 10.4149/neo_2022_211208N1749
- By:
- Publication type:
- Article
3
Does postpneumonectomy empyema improve long-term survival for patients with lung cancer?
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 723, doi. 10.4149/neo_2022_211207N1746
- By:
- Publication type:
- Article
4
Development of a model for predicting risk from breast interval cancer in the female population in the Republic of Croatia.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 708, doi. 10.4149/neo_2022_211118N1642
- By:
- Publication type:
- Article
5
Does the primary tumor site in stage I extranodal natural killer/T-cell lymphoma matter?
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 700, doi. 10.4149/neo_2022_211004N1407
- By:
- Publication type:
- Article
6
The predictive value and correlation of β-catenin, CMTM6, and PD-L1 expression in colorectal cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 691, doi. 10.4149/neo_2022_210809N1122
- By:
- Publication type:
- Article
7
New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker?
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 729, doi. 10.4149/neo_2022_220207N144
- By:
- Publication type:
- Article
8
CX3CL1 in the red bone marrow promotes renal cell carcinoma to metastasize to the spine by involving the Src-related pathway.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 670, doi. 10.4149/neo_2022_211205N1728
- By:
- Publication type:
- Article
9
CDC Like Kinase 2 plays an oncogenic role in colorectal cancer via modulating the Wnt/β-catenin signaling.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 657, doi. 10.4149/neo_2022_220206N138
- By:
- Publication type:
- Article
10
Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 648, doi. 10.4149/neo_2022_211103N1568
- By:
- Publication type:
- Article
11
ARHGAP17 enhances 5-fluorouracil-induced apoptosis in colon cancer cells by suppressing Rac1.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 640, doi. 10.4149/neo_2022_211006N1410
- By:
- Publication type:
- Article
12
Glucose and glutamine metabolism-related protein expression in breast ductal carcinoma in situ.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 630, doi. 10.4149/neo_2022_220103N3
- By:
- Publication type:
- Article
13
sh-HNF1A-AS1 reduces the epithelial-mesenchymal transition and stemness of esophageal cancer cells.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 560, doi. 10.4149/neo_2022_211102N1555
- By:
- Publication type:
- Article
14
Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signaling pathway.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 603, doi. 10.4149/neo_2022_211016N1474
- By:
- Publication type:
- Article
15
LncRNA NEAT1-associated aerobic glycolysis blunts tumor immunosurveillance by T cells in prostate cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 594, doi. 10.4149/neo_2022_211021N1497
- By:
- Publication type:
- Article
16
LncRNA BCYRN1 promotes cell migration and invasion of non-small cell lung cancer via the miR-30b-3p/ROCK1 axis.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 583, doi. 10.4149/neo_2022_210726N1045
- By:
- Publication type:
- Article
17
Exosomal circRNAs as novel potential biomarkers for colorectal adenoma.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 516, doi. 10.4149/neo_2021_210718N986
- By:
- Publication type:
- Article
18
Iodine-125-induced cholangiocarcinoma cell death is enhanced by inhibition of endoplasmic reticulum stress-mediated protective autophagy.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 620, doi. 10.4149/neo_2022_211102N1556
- By:
- Publication type:
- Article
19
Periostin: a predictable molecule to prognosis and chemotherapy responses of gastrointestinal and hepato-biliary-pancreatic malignant tumors?
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 491, doi. 10.4149/neo_2021_211025N1521
- By:
- Publication type:
- Article
20
Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 538, doi. 10.4149/neo_2022_210726N1046
- By:
- Publication type:
- Article
21
Identification of circRNAs involved in the development of hepatocellular carcinoma after insufficient radiofrequency ablation.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 527, doi. 10.4149/neo_2021_210817N1170
- By:
- Publication type:
- Article
22
Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 571, doi. 10.4149/neo_2022_211118N1640
- By:
- Publication type:
- Article
23
Drug therapy for bone metastasis of malignant tumor: theory, progress, and potential.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 504, doi. 10.4149/neo_2021_211006N1412
- By:
- Publication type:
- Article
24
Elevation of miR-125b-5p is related to improved prognosis in laryngeal squamous cell carcinoma and inhibits the malignancy and glycometabolic disorder by targeting MAP3K9.
- Published in:
- Neoplasma, 2022, v. 69, n. 3, p. 550, doi. 10.4149/neo_2022_211027N1532
- By:
- Publication type:
- Article